These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 15655016
1. Pseudomonas aeruginosa isolates recovered from clinical and environmental samples in Buea, Cameroon: current status on biotyping and antibiogram. Ndip RN, Dilonga HM, Ndip LM, Akoachere JF, Nkuo Akenji T. Trop Med Int Health; 2005 Jan; 10(1):74-81. PubMed ID: 15655016 [Abstract] [Full Text] [Related]
2. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. Gad GF, El-Domany RA, Zaki S, Ashour HM. J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321 [Abstract] [Full Text] [Related]
4. Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram. Ndip RN, Malange Takang AE, Ojongokpoko JE, Luma HN, Malongue A, Akoachere JF, Ndip LM, MacMillan M, Weaver LT. Trop Med Int Health; 2008 Jun; 13(6):848-54. PubMed ID: 18384477 [Abstract] [Full Text] [Related]
5. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital. Raja NS, Singh NN. J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906 [Abstract] [Full Text] [Related]
6. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics. Khan JA, Iqbal Z, Rahman SU, Farzana K, Khan A. Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431 [Abstract] [Full Text] [Related]
7. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R. Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175 [Abstract] [Full Text] [Related]
8. Antibiotic disc sensitivity pattern of pseudomonas aeruginosa isolates obtained from clinical specimens in Ilorin, Nigeria. Fadeyi A, Akanbi AA, Nwabuisi C, Onile BA. Afr J Med Med Sci; 2005 Sep; 34(3):303-6. PubMed ID: 16749366 [Abstract] [Full Text] [Related]
9. Antibiotic susceptibility and serotyping of Pseudomonas aeruginosa strains isolated from surface waters, thermomineral waters and clinical specimens. Reali D, Rosati S. Zentralbl Hyg Umweltmed; 1994 Aug; 196(1):75-80. PubMed ID: 7802899 [Abstract] [Full Text] [Related]
10. Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs. Erlandsson M, Gill H, Nordlinder D, Giske CG, Jonas D, Nilsson LE, Walther S, Hanberger H. Scand J Infect Dis; 2008 Aug; 40(6-7):487-94. PubMed ID: 18584536 [Abstract] [Full Text] [Related]
11. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan. Leung CH, Wang NY, Liu CP, Weng LC, Hsieh FC, Lee CM. J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693 [Abstract] [Full Text] [Related]
12. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005. Babay HA. Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646 [Abstract] [Full Text] [Related]
13. Serotyping, sites of isolation and resistance of Pseudomonas aeruginosa. Dette GA, Knothe H, Schäfer V, Pirlet-Berninger U. Microbiologica; 1988 Apr; 11(2):129-35. PubMed ID: 3136301 [Abstract] [Full Text] [Related]
14. Antibiotic sensitivity and plasmid profiles of Pseudomonas aeruginosa. Igumbor E, Gwanzura L, Chirara M, Obi C, Muza D. Cent Afr J Med; 2000 Nov; 46(11):296-300. PubMed ID: 12002119 [Abstract] [Full Text] [Related]
15. Are clinical isolates of Pseudomonas aeruginosa more virulent than hospital environmental isolates in amebal co-culture test? Fenner L, Richet H, Raoult D, Papazian L, Martin C, La Scola B. Crit Care Med; 2006 Mar; 34(3):823-8. PubMed ID: 16505663 [Abstract] [Full Text] [Related]
16. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: second national study (2003). Sánchez-Romero I, Cercenado E, Cuevas O, García-Escribano N, García-Martínez J, Bouza E, Spanish Group for Study of Pseudomonas aeruginosa. Rev Esp Quimioter; 2007 Jun; 20(2):222-9. PubMed ID: 17893760 [Abstract] [Full Text] [Related]
17. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms. Bosso JA, Mauldin PD, Steed LL. Ann Pharmacother; 2006 Nov; 40(11):1946-9. PubMed ID: 17018687 [Abstract] [Full Text] [Related]
18. Nosocomial cross-transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit. Mayank D, Anshuman M, Singh RK, Afzal A, Baronia AK, Prasad KN. Indian J Pathol Microbiol; 2009 Nov; 52(4):509-13. PubMed ID: 19805958 [Abstract] [Full Text] [Related]
19. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study. Walkty A, Decorby M, Nichol K, Mulvey MR, Hoban D, Zhanel G, Canadian Antimicrobial Resistance Alliance. Diagn Microbiol Infect Dis; 2008 Jun; 61(2):217-21. PubMed ID: 18304774 [Abstract] [Full Text] [Related]
20. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO. Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [Abstract] [Full Text] [Related] Page: [Next] [New Search]